m+Medelevator.RU
← Поиск публикаций
Public health action · 2025

Pulmonary rehabilitation for post-TB lung disease led by TB survivors.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Mtei F J, Meadows I, Msaji K, Thobias F, Liyoyo A, Kimaro A, Joseph P M, Gitige C, Kaswaga O, Matoi S, Ngoma A, Mbuya A, Mbelele P, Ritte L, Subi L, Neema P, Kisonga R, Mbwana D, Mpolya E, Drage M, Lochting L I, S K Heysell, S G Mpagama

Аннотация

BACKGROUND: Post-TB patients often experience persistent lung issues that impair exercise capacity and quality of life. Although pulmonary rehabilitation is known to be effective for chronic lung diseases, its role in post-TB lung disease remains underexplored in high TB-burden settings.

METHOD: This prospective study (2021-2022) in Tanzania's Kilimanjaro region evaluated a 24-week, community-based pulmonary rehabilitation program led by TB survivors for adults with moderate-to-severe respiratory symptoms despite TB cure. The program included supervised exercise, breathing training, psychosocial support and smoking cessation. Outcomes measured at baseline, 12 weeks, and 24 weeks included spirometry, 6-minute walk distance (6MWD), St. George's Respiratory Questionnaire (SGRQ), BMI, Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9).

RESULTS: Among 121 participants (mean age 48±8.67 years, 89.2% male), significant improvements were observed in 6MWD (420 vs. 460 meters, p < 0.001) and SGRQ scores (34.63 to 12.99, p < 0.001). Smoking history predicted SGRQ improvement. Although no changes were seen in lung function or BMI, anxiety and depression symptoms improved in those with abnormal baseline scores.

CONCLUSION: Community-based pulmonary rehabilitation improved symptomatic individuals' quality of life, physical capacity and mental health. Future research should refine intervention timing and evaluate long-term outcomes across diverse settings.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты